Genetic aberrations in the CDK4 pathway and association with innate resistance to PD-1 blockade in acral melanoma

被引：0
|
作者：
Yu, Jiayi
Kong, Yan
Chi, Zhihong
Tang, Bixia
Sheng, Xinan
Si, Lu
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.9588
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9588
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Original Research Palbociclib in advanced acral melanoma with genetic aberrations in the cyclin-dependent kinase 4 pathway
    Mao, Lili
    Dai, Jie
    Cao, Yabin
    Bai, Xue
    Sheng, Xinan
    Chi, Zhihong
    Cui, Chuanliang
    Kong, Yan
    Zhang, Yanxiang
    Wu, Lin
    Wang, Xuan
    Tang, Bixia
    Lian, Bin
    Yan, Xieqiao
    Li, Siming
    Zhou, Li
    Wei, Xiaoting
    Li, Caili
    Qi, Zhonghui
    Si, Lu
    Guo, Jun
    EUROPEAN JOURNAL OF CANCER, 2021, 148 : 297 - 306
  • [22] PD-1 blockade treatment in melanoma: Mechanism of response and tumor-intrinsic resistance
    Wang, Tong
    Ma, Wenjie
    Zou, Zijian
    Zhong, Jingqin
    Lin, Xinyi
    Liu, Wanlin
    Sun, Wei
    Hu, Tu
    Xu, Yu
    Chen, Yong
    CANCER SCIENCE, 2024,
  • [23] ERK hyperactivation serves as a unified mechanism of escape in intrinsic and acquired CDK4/6 inhibitor resistance in acral lentiginous melanoma
    Jagirdar, Kasturee
    Portuallo, Marie E.
    Wei, Meihan
    Wilhide, Matthew
    Bravo Narula, Jeremy A.
    Robertson, Bailey M.
    Alicea, Gretchen M.
    Aguh, Crystal
    Xiao, Min
    Godok, Tetiana
    Fingerman, Dylan
    Brown, Gregory Schuyler
    Herlyn, Meenhard
    Elad, Vissy M.
    Guo, Xinyu
    Toska, Eneda
    Zabransky, Daniel J.
    Wubbenhorst, Bradley
    Nathanson, Katherine L.
    Kwatra, Shawn
    Goyal, Yogesh
    Ji, Hongkai
    Liu, Qin
    Rebecca, Vito W.
    ONCOGENE, 2024, 43 (06) : 395 - 405
  • [24] ERK hyperactivation serves as a unified mechanism of escape in intrinsic and acquired CDK4/6 inhibitor resistance in acral lentiginous melanoma
    Kasturee Jagirdar
    Marie E. Portuallo
    Meihan Wei
    Matthew Wilhide
    Jeremy A. Bravo Narula
    Bailey M. Robertson
    Gretchen M. Alicea
    Crystal Aguh
    Min Xiao
    Tetiana Godok
    Dylan Fingerman
    Gregory Schuyler Brown
    Meenhard Herlyn
    Vissy M. Elad
    Xinyu Guo
    Eneda Toska
    Daniel J. Zabransky
    Bradley Wubbenhorst
    Katherine L. Nathanson
    Shawn Kwatra
    Yogesh Goyal
    Hongkai Ji
    Qin Liu
    Vito W. Rebecca
    Oncogene, 2024, 43 : 395 - 405
  • [25] CDK4/6 inhibition promotes immune infiltration in ovarian cancer and synergizes with PD-1 blockade in a B cell-dependent manner
    Zhang, Qian-Feng
    Li, Jia
    Jiang, Kuo
    Wang, Rui
    Ge, Jun-li
    Yang, Hong
    Liu, Shu-Juan
    Jia, Lin-Tao
    Wang, Lei
    Chen, Bi-Liang
    THERANOSTICS, 2020, 10 (23): : 10619 - 10633
  • [26] Identification of MicroRNA-mRNA Networks in Melanoma and Their Association with PD-1 Checkpoint Blockade Outcomes
    Sloane, Robert A. Szczepaniak
    White, Michael G.
    Witt, Russell G.
    Banerjee, Anik
    Davies, Michael A.
    Han, Guangchun
    Burton, Elizabeth
    Ajami, Nadim
    Simon, Julie M.
    Bernatchez, Chantale
    Haydu, Lauren E.
    Tawbi, Hussein A.
    Gershenwald, Jeffrey E.
    Keung, Emily
    Ross, Merrick
    McQuade, Jennifer
    Amaria, Rodabe N.
    Wani, Khalida
    Lazar, Alexander J.
    Woodman, Scott E.
    Wang, Linghua
    Andrews, Miles C.
    Wargo, Jennifer A.
    CANCERS, 2021, 13 (21)
  • [27] Genomic heterogeneity and ploidy identify patients with intrinsic resistance to PD-1 blockade in metastatic melanoma
    Tarantino, Giuseppe
    Ricker, Cora A.
    Wang, Annette
    Ge, William
    Aprati, Tyler J.
    Huang, Amy Y.
    Madha, Shariq
    Chen, Jiajia
    Shi, Yingxiao
    Glettig, Marc
    Feng, Catherine H.
    Frederick, Dennie T.
    Freeman, Samuel
    Holovatska, Marta M.
    Manos, Michael P.
    Zimmer, Lisa
    Roesch, Alexander
    Zaremba, Anne
    Livingstone, Elisabeth
    Jameson, Jacob C.
    Saghafian, Soroush
    Lee, Andrew
    Zhao, Karena
    Morris, Luc G. T.
    Reardon, Brendan
    Park, Jihye
    Elmarakeby, Haitham A.
    Schilling, Bastian
    Giobbie-Hurder, Anita
    Vokes, Natalie I.
    Buchbinder, Elizabeth I.
    Flaherty, Keith T.
    Haq, Rizwan
    Wu, Catherine J.
    Boland, Genevieve M.
    Hodi, F. Stephen
    Van Allen, Eliezer M.
    Schadendorf, Dirk
    Liu, David
    SCIENCE ADVANCES, 2024, 10 (48):
  • [28] Genomic heterogeneity and ploidy identify patients with intrinsic resistance to PD-1 blockade in metastatic melanoma
    Tarantino, Giuseppe
    Ricker, Cora A.
    Wang, Annette
    Ge, Will
    Huang, Amy Y.
    Madha, Shariq
    Chen, Jiajia
    Shi, Yingxiao
    Frederick, Dennie T.
    Freeman, Samuel
    Holovatska, Marta M.
    Manos, Michael P.
    Zimmer, Lisa
    Rosch, Alexander
    Zaremba, Anne
    Reardon, Brendan
    Park, Jihye
    Elmarakeby, Haitham
    Schilling, Bastian
    Giobbie-Hurder, Anita
    Vokes, Natalie
    Buchbinder, Elizabeth I.
    Flaherty, Keith
    Haq, Rizwan
    Wu, Catherine
    Boland, Genevieve
    Hodi, F. Stephen
    Van Allen, Eliezer
    Schadendorf, Dirk
    Liu, David
    CANCER RESEARCH, 2023, 83 (07)
  • [29] WEE1 confers resistance to PD-1 blockade via hyperactivation of the AKT signaling pathway
    Lee, Hyo-Jung
    Kim, Suyeon
    Cho, Eunho
    Kim, Tae Woo
    CANCER RESEARCH, 2024, 84 (22)
  • [30] Association of NRAS mutations and tertiary lymphoid structure formation with clinical outcomes of adjuvant PD-1 inhibitors for acral melanoma
    Mo, Zeming
    Liu, Jie
    Zhang, Jinyan
    Deng, Yaotiao
    Xu, Miao
    Jiang, Yu
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 124
12345